Page 6 - Director Eric News Today

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective cut by research analysts at UBS Group from $250.00 to $214.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the biotechnology company’s stock. UBS Group’s price objective indicates a potential upside of 11.37% from the stock’s […]

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective reduced by analysts at UBS Group from $250.00 to $214.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. UBS Group’s price objective points to a potential upside of 11.37% from the […]

Flputnam Investment Management Co. reduced its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,931 shares of the biotechnology company’s stock after selling 185 shares during the […]

Flputnam Investment Management Co. decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,931 shares of the biotechnology company’s stock after selling 185 shares during the […]

Tobam reduced its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 7.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,922 shares of the biotechnology company’s stock after selling 933 shares during the quarter. Tobam’s holdings in Biogen were worth […]

Tritonpoint Wealth LLC bought a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,023 shares of the biotechnology company’s stock, valued at approximately $523,000. Other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought […]

Tritonpoint Wealth LLC acquired a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,023 shares of the biotechnology company’s stock, valued at approximately $523,000. Other large investors have also recently bought and sold […]

Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-seven analysts that are covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12-month price objective […]

Texas Pacific Land Co. (NYSE:TPL – Get Free Report) shares traded up 2.4% during trading on Tuesday . The stock traded as high as $585.00 and last traded at $585.00. 5,147 shares traded hands during trading, a decline of 93% from the average session volume of 70,656 shares. The stock had previously closed at $571.09. […]

Camelot Portfolios LLC raised its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 81.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,000 shares of the biotechnology company’s stock after acquiring an additional 900 shares during […]